JULIO
PASCUAL SANTOS
Profesor asociado de Ciencias de la Salud
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (35)
2023
-
Best practices during COVID-19 pandemic in solid organ transplant programs in Spain
Transplantation Reviews, Vol. 37, Núm. 1
-
Erratum to “Recommendations for living donor kidney transplantation” (NEFROLOGIA (English Edition) (2022) 42(S2) (1–4), (S2013251422001444), (10.1016/j.nefroe.2022.01.009))
Nefrologia
2022
-
Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients
Transplantation, Vol. 106, Núm. 7, pp. 1430-1439
-
Recommendations for living donor kidney transplantation
Nefrologia, Vol. 42, pp. 5-132
2021
-
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: Proof-of-concept study
BMJ Open, Vol. 11, Núm. 10
-
Hemodialysis Centers Guide 2020
Nefrologia, Vol. 41, pp. 1-77
-
Kidney transplant outcomes in elderly recipients with controlled donation after circulatory death or donation after brain death donors: a registry cohort study
Transplant International, Vol. 34, Núm. 12, pp. 2507-2514
-
Mortality in hemodialysis patients with covid-19, the effect of paricalcitol or calcimimetics
Nutrients, Vol. 13, Núm. 8
2020
-
Assessing the Limits in Kidney Transplantation: Use of Extremely Elderly Donors and Outcomes in Elderly Recipients
Transplantation, Vol. 104, Núm. 1, pp. 176-183
-
Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients
Transplantation, Vol. 104, Núm. 11, pp. 2225-2233
-
Risk factors for non-diabetic renal disease in diabetic patients
Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388
2019
-
ACE2 and ACE in acute and chronic rejection after human heart transplantation
International Journal of Cardiology, Vol. 275, pp. 59-64
-
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients
Transplantation Reviews, Vol. 33, Núm. 4, pp. 191-199
-
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study
American Journal of Transplantation, Vol. 19, Núm. 11, pp. 3018-3034
2018
-
Bloqueo del sistema renina-angiotensina-aldosterona en pacientes con enfermedad renal diabética avanzada
Nefrologia, Vol. 38, Núm. 2, pp. 220-221
-
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation
Journal of the American Society of Nephrology, Vol. 29, Núm. 7, pp. 1979-1991
2017
-
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial
American Journal of Transplantation, Vol. 17, Núm. 7, pp. 1853-1867
-
Serum osteoprotegerin in prevalent hemodialysis patients: Associations with mortality, atherosclerosis and cardiac function
BMC Nephrology, Vol. 18, Núm. 1
-
mTOR intersects antibody-inducing signals from TACI in marginal zone B cells
Nature Communications, Vol. 8, Núm. 1
2016
-
Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation
Transplant International, Vol. 29, Núm. 12, pp. 1317-1328